The miRNA ‐ mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO
Cancer Reports · 2025
DOI: 10.1002/cnr2.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Razieh Heidari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Gene Regulatory Networks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahrekord University of Medical Sciences.
Abstract (Originalsprache)
Background
Bioinformatics analysis of hepatocellular carcinoma (HCC) expression profiles can aid in understanding its molecular mechanisms and identifying new targets for diagnosis and treatment.
Aim
In this study, we analyzed expression profile datasets and miRNA expression profiles related to HCC from the GEO using R software to detect differentially expressed genes (DEGs) and differentially expressed miRNAs (DEmiRs). Methods and results Common DEGs were identified, and a PPI network was constructed using the STRING database and Cytoscape software to identify hub genes. The reduced levels of tumor suppressor miRNAs or down regulated DEmiRs may be increased levels of oncogenes, the oncomirs or up regulated DEmiRs may be decreased levels of tumor suppressor genes in cancerous cells. According to this strategy, increased and decreased DEGs, also increased and decreased DEmiRs were selected. The multimir package was employed to predict target genes for DEmiRs then DEmiRs‐hub gene network created. We identified approximately 1000 overlapping DEGs and 60 DEmiRs. Hub genes included RRM2, MELK , KIF11 , KIF23 , NCAPG , DLGAP5 , BUB1B , AURKB , CCNB1 , KIF20A , CCNA2 , TTK , PBK , TOP2A , CDK1 , MAD2L1 , BIRC5 , ASPM , CDCA8 , and CENPF , all associated with significantly worse survival in HCC. miR‐224, miR‐24, miR‐182, miRNA‐1‐3p, miR‐30a, miR‐27a, and miR‐214 were identified as important DEmiRs with targeting more than six hub genes.
Conclusion
Generally, our findings offer insight into the interaction of hub genes and miRNAs in the development of HCC by bioinformatics analysis, information that may prove useful in identifying biomarkers and therapeutic targets in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
- Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
- Department of Tissue Engineering & Applied Cell Sciences, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
- Advanced Technology Cores, Baylor College of Medicine, Texas, USA.
- Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
ORCID-Profile: Razieh Heidari, Vahideh Assadollahi, Seyedeh Negar Marashi, Fatemeh Elahian, Seyed Abbas Mirzaei
Förderung
- Shahrekord University of Medical Sciences
Zitieren
APA
Heidari, R., Assadollahi, V., Marashi, S. N., Elahian, F., & Mirzaei, S. A. (2025). The miRNA ‐ mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO. Cancer Reports. https://doi.org/10.1002/cnr2.70098
Vancouver
Heidari R, Assadollahi V, Marashi SN, Elahian F, Mirzaei SA. The miRNA ‐ mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO. Cancer Reports. 2025. doi:10.1002/cnr2.70098
BibTeX
@article{Heidari2025,
author = {Heidari, Razieh and Assadollahi, Vahideh and Marashi, Seyedeh Negar and Elahian, Fatemeh and Mirzaei, Seyed Abbas},
title = {The miRNA ‐ mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70098}
}
EUVIMED